These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 19046006)

  • 1. Risk factors for development of neurologic disease after experimental exposure to equine herpesvirus-1 in horses.
    Allen GP
    Am J Vet Res; 2008 Dec; 69(12):1595-600. PubMed ID: 19046006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of metaphylactic RNA interference to prevent equine herpesvirus type 1 infection in experimental herpesvirus myeloencephalopathy in horses.
    Perkins GA; Van de Walle GR; Pusterla N; Erb HN; Osterrieder N
    Am J Vet Res; 2013 Feb; 74(2):248-56. PubMed ID: 23363350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antemortem detection of latent infection with neuropathogenic strains of equine herpesvirus-1 in horses.
    Allen GP
    Am J Vet Res; 2006 Aug; 67(8):1401-5. PubMed ID: 16881853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of viral loads, strain and state of equine herpesvirus-1 using real-time PCR in horses following natural exposure at a racetrack in California.
    Pusterla N; Wilson WD; Mapes S; Finno C; Isbell D; Arthur RM; Ferraro GL
    Vet J; 2009 Feb; 179(2):230-9. PubMed ID: 18024200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental infection with neuropathogenic equid herpesvirus type 1 (EHV-1) in adult horses.
    Goehring LS; van Maanen C; Berendsen M; Cullinane A; de Groot RJ; Rottier PJ; Wesselingh JJ; Sloet van Oldruitenborgh-Oosterbaan MM
    Vet J; 2010 Nov; 186(2):180-7. PubMed ID: 19726209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum antibody responses to equine herpesvirus 1 glycoprotein D in horses, pregnant mares and young foals.
    Foote CE; Love DN; Gilkerson JR; Rota J; Trevor-Jones P; Ruitenberg KM; Wellington JE; Whalley JM
    Vet Immunol Immunopathol; 2005 May; 105(1-2):47-57. PubMed ID: 15797474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of latent, neuropathogenic equine herpesvirus-1 in the Thoroughbred broodmare population of central Kentucky.
    Allen GP; Bolin DC; Bryant U; Carter CN; Giles RC; Harrison LR; Hong CB; Jackson CB; Poonacha K; Wharton R; Williams NM
    Equine Vet J; 2008 Mar; 40(2):105-10. PubMed ID: 18089469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropathogenic and non-neuropathogenic variants of equine herpesvirus 1 in France.
    Pronost S; Léon A; Legrand L; Fortier C; Miszczak F; Freymuth F; Fortier G
    Vet Microbiol; 2010 Oct; 145(3-4):329-33. PubMed ID: 20427133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Equine Herpesvirus Type 1 (EHV-1) Ab4 Open Reading Frame 2 Deletion Mutant Provides Immunity and Protection from EHV-1 Infection and Disease.
    Schnabel CL; Babasyan S; Rollins A; Freer H; Wimer CL; Perkins GA; Raza F; Osterrieder N; Wagner B
    J Virol; 2019 Nov; 93(22):. PubMed ID: 31462575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The increased prevalence of neuropathogenic strains of EHV-1 in equine abortions.
    Smith KL; Allen GP; Branscum AJ; Frank Cook R; Vickers ML; Timoney PJ; Balasuriya UB
    Vet Microbiol; 2010 Feb; 141(1-2):5-11. PubMed ID: 19733451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody and cellular immune responses following DNA vaccination and EHV-1 infection of ponies.
    Soboll G; Hussey SB; Whalley JM; Allen GP; Koen MT; Santucci N; Fraser DG; Macklin MD; Swain WF; Lunn DP
    Vet Immunol Immunopathol; 2006 May; 111(1-2):81-95. PubMed ID: 16549215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Equine herpesvirus-1 infection induces IFN-gamma production by equine T lymphocyte subsets.
    Breathnach CC; Soboll G; Suresh M; Lunn DP
    Vet Immunol Immunopathol; 2005 Feb; 103(3-4):207-15. PubMed ID: 15621307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the efficacy of inactivated combination and modified-live virus vaccines against challenge infection with neuropathogenic equine herpesvirus type 1 (EHV-1).
    Goodman LB; Wagner B; Flaminio MJ; Sussman KH; Metzger SM; Holland R; Osterrieder N
    Vaccine; 2006 Apr; 24(17):3636-45. PubMed ID: 16513225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of equine herpesvirus-specific effector and memory cytotoxic immunity in the equine upper respiratory tract.
    Breathnach CC; Yeargan MR; Timoney JF; Allen GP
    Vet Immunol Immunopathol; 2006 May; 111(1-2):117-25. PubMed ID: 16472871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Equine herpesvirus-1 myeloencephalopathy: a review of recent developments.
    Pusterla N; David Wilson W; Madigan JE; Ferraro GL
    Vet J; 2009 Jun; 180(3):279-89. PubMed ID: 18805030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The first reported outbreak of equine herpesvirus myeloencephalopathy in New Zealand.
    McFadden AM; Hanlon D; McKenzie RK; Gibson I; Bueno IM; Pulford DJ; Orr D; Dunowska M; Stanislawek WL; Spence RP; McDonald WL; Munro G; Mayhew IG
    N Z Vet J; 2016 Mar; 64(2):125-34. PubMed ID: 26414406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency and phenotype of EHV-1 specific, IFN-gamma synthesising lymphocytes in ponies: the effects of age, pregnancy and infection.
    Paillot R; Daly JM; Luce R; Montesso F; Davis-Poynter N; Hannant D; Kydd JH
    Dev Comp Immunol; 2007; 31(2):202-14. PubMed ID: 16824599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of DNA and recombinant canarypox viral (ALVAC) vectors for equine herpes virus vaccination.
    Minke JM; Fischer L; Baudu P; Guigal PM; Sindle T; Mumford JA; Audonnet JC
    Vet Immunol Immunopathol; 2006 May; 111(1-2):47-57. PubMed ID: 16580075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence factors associated with equine herpesvirus type 1 infection in equids with upper respiratory tract infection and/or acute onset of neurological signs from 2008 to 2014.
    Pusterla N; Mapes S; Akana N; Barnett C; MacKenzie C; Gaughan E; Craig B; Chappell D; Vaala W
    Vet Rec; 2016 Jan; 178(3):70. PubMed ID: 26607427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum iron parameters and acute experimental EHV-1 infection in horses.
    Brosnahan MM; Erb HN; Perkins GA; Divers TJ; Borges AS; Osterrieder N
    J Vet Intern Med; 2012; 26(5):1232-5. PubMed ID: 22748124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.